CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...